EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Clinical Benefits of Exogenous Ketosis in Adults with Disease: A Systematic Review

Othmane Mohib iD, Sarah Bomans iD, Berenice Jimenez Garcia iD, Lynn Leemans, Claudine Ligneel, Elisabeth De Waele iD, David Beckwée iD, Peter Janssens iD

Nutrients · 30.09.2025 · 17 (19) · 3125

DOI: 10.3390/nu17193125 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Nutrients, online erschienen am 30.09.2025. Verfasst von Othmane Mohib und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Arterial Hypertension, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101,…. Hauptthemen laut MEDLINE: Ketosis, Ketone Bodies, Metabolic Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Foundation - Flanders, Fonds Wetenschappelijk Onderzoek, Wetenschappelijk Fonds Willy Gepts.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Ketone bodies are increasingly studied for their potential therapeutic effects, particularly through exogenous ketosis, in a variety of diseases. This systematic review aimed to rigorously assess the clinical efficacy of exogenous ketosis in adults with medical conditions.

Methods

Following PRISMA guidelines, we systematically searched MEDLINE and Scopus databases. Our inclusion criteria were defined according to the PICOS framework, focusing on studies involving exogenous ketosis in adult patients with specific diseases. The study is registered in the International Prospective Register of Systematic Reviews (PROSPERO; CRD42023492846).

Results

After a stringent selection process, fifty-one studies were analyzed. Twenty-two studies focused on neurological disorders, one on psychiatric disorders, twenty-two on metabolic disorders, five on cardiovascular disorders, and one on an inflammatory disorder. Exogenous ketosis demonstrated potential benefits across multiple conditions, including Alzheimer’s disease, mild cognitive impairment, McArdle’s disease, various forms of heart failure, cardiogenic shock, pulmonary hypertension, and COVID-19-related acute respiratory distress syndrome, although evidence is mostly limited to surrogate endpoints with insufficient hard outcome data. Subtherapeutic ketone concentrations induced by medium-chain triglycerides and limited follow-up periods often precluded firm conclusions regarding clinically meaningful outcomes.

Conclusions

Exogenous ketosis shows potential in neurological, metabolic, and cardiovascular disorders, while evidence in psychiatric and inflammatory conditions remains scarce and preliminary. Ketone esters appear preferable for effective and tolerable ketosis. Future research should focus on identifying responsive patient populations, optimizing treatment regimens, and conducting long-term clinical trials with hard endpoints to validate these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KetosisKetone BodiesMetabolic DiseasesHumansAdultCardiovascular DiseasesCOVID-19Mental DisordersNervous System Diseases

Stichwörter der Autor:innen

exogenous ketosisketone esterketone saltketosismedium-chain triglycerides

Substanzen

Ketone Bodies

Autor:innen und Institutionen

  • Department of Nephrology and Arterial Hypertension, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, 1090 Brussels, Belgium.
  • Vitality Research Group, Vrije Universiteit Brussel (VUB), 1090 Brussels, Belgium.
  • Department of Clinical Nutrition and Dietetics, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, 1090 Brussels, Belgium.
  • Department of Clinical Pharmacology and Pharmacotherapy, Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, 1090 Brussels, Belgium.
  • Rehabilitation Research Department, Vrije Universiteit Brussel (VUB), 1090 Brussels, Belgium.

ORCID-Profile: Othmane Mohib, Sarah Bomans, Berenice Jimenez Garcia, Elisabeth De Waele, David Beckwée, Peter Janssens

Förderung

  • Research Foundation - Flanders
  • Fonds Wetenschappelijk Onderzoek
  • Wetenschappelijk Fonds Willy Gepts

Zitieren

APA

Mohib, O., Bomans, S., Jimenez Garcia, B., Leemans, L., Ligneel, C., De Waele, E., Beckwée, D., & Janssens, P. (2025). Clinical Benefits of Exogenous Ketosis in Adults with Disease: A Systematic Review. Nutrients, 17(19), 3125. https://doi.org/10.3390/nu17193125

Vancouver

Mohib O, Bomans S, Jimenez Garcia B, Leemans L, Ligneel C, De Waele E, et al. Clinical Benefits of Exogenous Ketosis in Adults with Disease: A Systematic Review. Nutrients. 2025;17(19):3125. doi:10.3390/nu17193125

BibTeX
@article{Mohib2025,
  author = {Mohib, Othmane and Bomans, Sarah and Jimenez Garcia, Berenice and Leemans, Lynn and Ligneel, Claudine and De Waele, Elisabeth and Beckwée, David and Janssens, Peter},
  title = {Clinical Benefits of Exogenous Ketosis in Adults with Disease: A Systematic Review},
  journal = {Nutrients},
  year = {2025},
  volume = {17},
  number = {19},
  pages = {3125},
  doi = {10.3390/nu17193125}
}
Kostenlos starten →